{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:02:46Z","timestamp":1788379366305,"version":"build-2803163510"},"reference-count":98,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,1,5]]},"abstract":"<jats:p>Background: Accumulation of hyperphosphorylated tau (pTau) protein is associated with synaptic dysfunction in Alzheimer\u2019s disease (AD). We previously demonstrated that neuroprotection in familial mouse models of AD could be achieved by targeting mitochondria complex I (MCI) and activating the adaptive stress response. Efficacy of this strategy on pTau-related pathology remained unknown. Objective: To investigate the effect of specific MCI inhibitor tricyclic pyrone compound CP2 on levels of human pTau, memory function, long term potentiation (LTP), and energy homeostasis in 18-month-old 3xTg-AD mice and explore the potential mechanisms. Methods: CP2 was administered to male and female 3xTg-AD mice from 3.5\u201318 months of age. Cognitive function was assessed using the Morris water maze. Glucose metabolism was measured in periphery using a glucose tolerance test and in the brain using fluorodeoxyglucose F18 positron-emission tomography (FDG-PET). LTP was evaluated using electrophysiology in the hippocampus. The expression of key proteins associated with neuroprotective mechanisms were assessed by western blotting. Results: Chronic CP2 treatment restored synaptic activity in female 3xTg-AD mice; cognitive function, levels of synaptic proteins, glucose metabolism, and energy homeostasis were improved in male and female 3xTg-AD mice. Significant reduction of human pTau in the brain was associated with increased activity of protein phosphatase of type 2A (PP2A), and reduced activity of cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3\u03b2 (GSK3\u03b2). Conclusion: CP2 treatment protected against synaptic dysfunction and memory impairment in symptomatic 3xTg-AD mice, and reduced levels of human pTau, indicating that targeting mitochondria with small molecule specific MCI inhibitors represents a promising strategy for treating AD.<\/jats:p>","DOI":"10.3233\/jad-201015","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T16:00:45Z","timestamp":1606838445000},"page":"335-353","source":"Crossref","is-referenced-by-count":33,"title":["Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice"],"prefix":"10.1177","volume":"79","author":[{"given":"Andrea","family":"Stojakovic","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Youne","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA"},{"name":"Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarred","family":"Nesbitt","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Pichurin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ostroot","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Trushina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"},{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201015_ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201015_ref2","doi-asserted-by":"crossref","first-page":"e21521","DOI":"10.1371\/journal.pone.0021521","article-title":"Molecular implication of PP2A and Pin1 in the Alzheimer\u2019s disease specific hyperphosphorylation of Tau","volume":"6","author":"Landrieu","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201015_ref3","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-201015_ref4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: Follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.3233\/JAD-201015_ref5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neurobiolaging.2007.03.007","article-title":"Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer\u2019s disease","volume":"29","author":"Akram","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201015_ref6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders","volume":"14","author":"Penzes","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-201015_ref7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.3233\/JAD-201015_ref8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-201015_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11571-007-9033-x","article-title":"The physiological and biochemical bases of functional brain imaging","volume":"2","author":"Sokoloff","year":"2008","journal-title":"Cogn Neurodyn"},{"key":"10.3233\/JAD-201015_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-013-0026-y"},{"key":"10.3233\/JAD-201015_ref11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fnana.2019.00099","article-title":"Subregional density of neurons, neuro-fibrillary tangles and amyloid plaques in the hippocampus of patients with Alzheimer\u2019s disease","volume":"13","author":"Furcila","year":"2019","journal-title":"Front Neuroanat"},{"key":"10.3233\/JAD-201015_ref12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-201015_ref13","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","article-title":"Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers","volume":"34","author":"Frandemiche","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-201015_ref15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.M008085200","article-title":"Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor","volume":"276","author":"Nakazawa","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201015_ref16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2017.05.056","article-title":"Microtubule-associated tau contributes to intra-dendritic trafficking of AMPA receptors in multiple ways","volume":"653","author":"Suzuki","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-201015_ref17","doi-asserted-by":"crossref","first-page":"E6983","DOI":"10.1073\/pnas.1517045112","article-title":"PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201015_ref18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00429-014-0927-1","article-title":"Phosphorylation of the AMPA receptor GluA1 subunit regulates memory load capacity","volume":"221","author":"Olivito","year":"2016","journal-title":"Brain Struct Funct"},{"key":"10.3233\/JAD-201015_ref19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(03)00122-3","article-title":"Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory","volume":"112","author":"Lee","year":"2003","journal-title":"Cell"},{"key":"10.3233\/JAD-201015_ref20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0896-6273(03)00681-0","article-title":"Tau phosphorylation, tangles, and neurodegeneration: The chicken or the egg?","volume":"40","author":"Geschwind","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-201015_ref21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-201015_ref22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-201015_ref23","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1073\/pnas.0501881102","article-title":"Glutamate induces the rapid formation of spine head protrusions in hippocampal slice cultures","volume":"102","author":"Richards","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201015_ref24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1113\/jphysiol.2009.178905","article-title":"Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling","volume":"588","author":"McKinney","year":"2010","journal-title":"J Physiol"},{"key":"10.3233\/JAD-201015_ref25","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-201015_ref26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2014.00016","article-title":"Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease","volume":"7","author":"Sontag","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-201015_ref27","doi-asserted-by":"crossref","first-page":"14984","DOI":"10.1074\/jbc.M111.338681","article-title":"The protein phosphatase PP2A\/B\u03b1 binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: Implications for tauopathies","volume":"287","author":"Sontag","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201015_ref28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","article-title":"PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta","volume":"19","author":"Qian","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201015_ref29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4196\/kjpp.2014.18.2.155","article-title":"Regulatory B subunits of protein phosphatase 2A are involved in site-specific regulation of tau protein phosphorylation","volume":"18","author":"Yu","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.3233\/JAD-201015_ref30","doi-asserted-by":"crossref","first-page":"25457","DOI":"10.1074\/jbc.M603469200","article-title":"The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation","volume":"281","author":"Plattner","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201015_ref31","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1523\/JNEUROSCI.21-20-07985.2001","article-title":"An NMDA receptor signaling complex with protein phosphatase 2A","volume":"21","author":"Chan","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1582-4934.2008.00249.x","article-title":"Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology","volume":"12","author":"Liu","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-201015_ref33","first-page":"226","article-title":"Alzheimer prevention hopes continue to dim","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-201015_ref34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-201015_ref35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-201015_ref36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrd3288","article-title":"Alzheimer\u2019s failure raises questions about disease-modifying strategies","volume":"9","author":"Extance","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-201015_ref37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201015_ref38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-201015_ref39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-201015_ref40","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: A randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.3233\/JAD-201015_ref41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-016-0189-7","article-title":"Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials","volume":"8","author":"Vandenberghe","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-201015_ref42","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.3390\/ijms130910771","article-title":"Adaptive response, evidence of cross-resistance and its potential clinical use","volume":"13","author":"Milisav","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-201015_ref43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/br.2016.607","article-title":"Role of physical exercise in Alzheimer\u2019s disease","volume":"4","author":"Chen","year":"2016","journal-title":"Biomed Rep"},{"key":"10.3233\/JAD-201015_ref44","doi-asserted-by":"crossref","first-page":"9874159","DOI":"10.1155\/2019\/9874159","article-title":"Nutrients in the prevention of Alzheimer\u2019s disease","volume":"2019","author":"Cremonini","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JAD-201015_ref45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1039\/C9FO02611H","article-title":"The effects of caloric restriction and its mimetics in Alzheimer\u2019s disease through autophagy pathways","volume":"11","author":"Yang","year":"2020","journal-title":"Food Funct"},{"key":"10.3233\/JAD-201015_ref46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.arr.2011.12.005","article-title":"AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network","volume":"11","author":"Salminen","year":"2012","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-201015_ref47","first-page":"109","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease and progress in mitochondria-targeted therapeutics","volume":"98","author":"Flannery","year":"2019","journal-title":"Curr Behav Neurosci Rep"},{"key":"10.3233\/JAD-201015_ref48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ebiom.2015.03.009","article-title":"Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer\u2019s disease","volume":"2","author":"Zhang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.3233\/JAD-201015_ref50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-201015_ref51","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1016\/S0040-4020(03)00687-2","article-title":"Syntheses and bioactivities of tricyclic pyrones","volume":"59","author":"Hua","year":"2003","journal-title":"Tetrahedron"},{"key":"10.3233\/JAD-201015_ref52","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1523\/JNEUROSCI.6192-11.2012","article-title":"A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons","volume":"32","author":"Ghosh","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref53","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","article-title":"Neuronal clearance of amyloid-beta by endocytic receptor LRP1","volume":"33","author":"Kanekiyo","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref54","first-page":"126","article-title":"Low-mass molecular dynamics simulation for configurational sampling enhancement: More evidence and theoretical explanation","volume":"4","author":"Pang","year":"2015","journal-title":"Biochem Biophys Rep"},{"key":"10.3233\/JAD-201015_ref55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2007.06.013","article-title":"Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice","volume":"28","author":"Clinton","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-201015_ref56","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1096\/fj.14-268482","article-title":"Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"29","author":"Vandal","year":"2015","journal-title":"FASEB J"},{"key":"10.3233\/JAD-201015_ref57","doi-asserted-by":"crossref","first-page":"e69830","DOI":"10.1371\/journal.pone.0069830","article-title":"Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer\u2019s disease","volume":"8","author":"Sancheti","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201015_ref58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: A longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-201015_ref59","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1073\/pnas.82.17.6010","article-title":"Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat","volume":"82","author":"Kadekaro","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201015_ref60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: Long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.3233\/JAD-201015_ref61","doi-asserted-by":"crossref","first-page":"e12791","DOI":"10.1111\/acel.12791","article-title":"Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"17","author":"Baglietto-Vargas","year":"2018","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-201015_ref62","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/0008-5472.CAN-08-2641","article-title":"Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res"},{"key":"10.3233\/JAD-201015_ref63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ceca.2012.12.001","article-title":"AMPK activity is regulated by calcium-mediated protein phosphatase 2A activity","volume":"53","author":"Park","year":"2013","journal-title":"Cell Calcium"},{"key":"10.3233\/JAD-201015_ref64","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1074\/jbc.M709585200","article-title":"Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt","volume":"283","author":"Kuo","year":"2008","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201015_ref65","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nn736","article-title":"Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons","volume":"4","author":"Matsuzaki","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-201015_ref66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-201015_ref67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.3233\/JAD-201015_ref68","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","article-title":"Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease","volume":"25","author":"Chin","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev.cellbio.23.090506.123516","article-title":"The cell biology of synaptic plasticity: AMPA receptor trafficking","volume":"23","author":"Shepherd","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.3233\/JAD-201015_ref70","doi-asserted-by":"crossref","first-page":"13200","DOI":"10.1523\/JNEUROSCI.0061-12.2012","article-title":"The balance between receptor recycling and trafficking toward lysosomes determines synaptic strength during long-term depression","volume":"32","author":"Fern\u00e1ndez-Monreal","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref71","doi-asserted-by":"crossref","first-page":"20033","DOI":"10.1073\/pnas.0910338106","article-title":"Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation","volume":"106","author":"He","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201015_ref72","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/sj.emboj.7601156","article-title":"NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity","volume":"25","author":"Nakazawa","year":"2006","journal-title":"EMBO J"},{"key":"10.3233\/JAD-201015_ref73","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1523\/JNEUROSCI.5667-08.2009","article-title":"Tyrosine phosphorylation of the 2B subunit of the NMDA receptor is necessary for taste memory formation","volume":"29","author":"Barki-Harrington","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201015_ref74","doi-asserted-by":"crossref","first-page":"e78919","DOI":"10.1371\/journal.pone.0078919","article-title":"The central role of AMP-kinase and energy homeostasis impairment in Alzheimer\u2019s disease: A multifactor network analysis","volume":"8","author":"Caberlotto","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201015_ref75","doi-asserted-by":"crossref","first-page":"4209475","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3beta at the intersection of neuronal plasticity and neurodegeneration","volume":"2019","author":"Jaworski","year":"2019","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-201015_ref76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jnc.14608","article-title":"Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease","volume":"149","author":"Cisternas","year":"2019","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201015_ref77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jnen\/63.4.287","article-title":"Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology","volume":"63","author":"Sontag","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-201015_ref78","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1073\/pnas.1018777108","article-title":"Mice lacking phosphatase PP2A subunit PR61\/B\u2019delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta","volume":"108","author":"Louis","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201015_ref79","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-4159.2008.05866.x","article-title":"Inhibition of Alzheimer\u2019s amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo","volume":"108","author":"Hong","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201015_ref80","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: A systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201015_ref81","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-201015_ref82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.003","article-title":"Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer\u2019s disease","volume":"58","author":"Velazquez","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-201015_ref83","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41467-020-14959-w","article-title":"Sex and APOE epsilon4 genotype modify the Alzheimer\u2019s disease serum metabolome","volume":"11","author":"Arnold","year":"2020","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-201015_ref84","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White matter lipids as a ketogenic fuel supply in aging female brain: Imlications for Alzheimer\u2019s disease","volume":"2","author":"Klosinski","year":"2015","journal-title":"EBioMedicine"},{"key":"10.3233\/JAD-201015_ref85","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41591-020-0797-4","article-title":"Another step forward in blood-based diagnostics for Alzheimer\u2019s disease","volume":"26","author":"Bateman","year":"2020","journal-title":"Nat Med"},{"key":"10.3233\/JAD-201015_ref86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng1056","article-title":"A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity","volume":"33","author":"Lee","year":"2003","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-201015_ref87","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.1077780","article-title":"Rates of behavior and aging specified by mitochondrial function during development","volume":"298","author":"Dillin","year":"2002","journal-title":"Science"},{"key":"10.3233\/JAD-201015_ref88","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1534-5807(01)00071-5","article-title":"Mitochondrial electron transport is a key determinant of life span in Caenorhabditis elegans","volume":"1","author":"Feng","year":"2001","journal-title":"Dev Cell"},{"key":"10.3233\/JAD-201015_ref89","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1101\/gad.1308205","article-title":"A systematic RNAi screen for longevity genes in C. elegans","volume":"19","author":"Hamilton","year":"2005","journal-title":"Genes Dev"},{"key":"10.3233\/JAD-201015_ref90","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1074\/jbc.C000889200","article-title":"Altered quinone biosynthesis in the long-lived clk-1 mutants of Caenorhabditis elegans","volume":"276","author":"Miyadera","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-201015_ref91","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cels.2016.01.014","article-title":"Longitudinal RNA-seq analysis of vertebrate aging identifies mitochondrial complex I as a small-molecule-sensitive modifier of lifespan","volume":"2","author":"Baumgart","year":"2016","journal-title":"Cell Syst"},{"key":"10.3233\/JAD-201015_ref92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acel.12186","article-title":"The co-occurrence of mtDNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specific","volume":"13","author":"Raule","year":"2014","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-201015_ref93","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-201015_ref94","doi-asserted-by":"crossref","first-page":"2315106","DOI":"10.1155\/2020\/2315106","article-title":"Metformin ameliorates Abeta pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer\u2019s disease","volume":"2020","author":"Lu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JAD-201015_ref95","doi-asserted-by":"crossref","first-page":"dgz234","DOI":"10.1210\/clinem\/dgz234","article-title":"Metformin and risk of Alzheimer\u2019s disease among community-dwelling people with diabetes: A national case-control study","volume":"105","author":"Sluggett","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JAD-201015_ref96","doi-asserted-by":"crossref","first-page":"13753","DOI":"10.1038\/s41598-017-12974-4","article-title":"Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex","volume":"7","author":"Schweiger","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-201015_ref97","doi-asserted-by":"crossref","first-page":"e0144290","DOI":"10.1371\/journal.pone.0144290","article-title":"Resveratrol directly binds to mitochondrial complex I and increases oxidative stress in brain mitochondria of aged mice","volume":"10","author":"Gueguen","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-201015_ref98","first-page":"87","article-title":"Effects of resveratrol on the rat brain respiratory chain","volume":"25","author":"Zini","year":"1999","journal-title":"Drugs Exp Clin Res"},{"key":"10.3233\/JAD-201015_ref99","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/sj.bjp.0703397","article-title":"Inhibition of mitochondrial proton F0F1-ATPase\/ATP synthase by polyphenolic phytochemicals","volume":"130","author":"Zheng","year":"2000","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:33Z","timestamp":1777370673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":98,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-201015","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.19.258236","asserted-by":"object"}]},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]}}}